Evaluating natural history and treatment response in cardiac amyloidosis: the evolving role of multimodality imaging.

Saved in:
Bibliographic Details
Title: Evaluating natural history and treatment response in cardiac amyloidosis: the evolving role of multimodality imaging.
Authors: Walser A; Cardiac Imaging, Department of Cardiology and Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, Zurich CH-8091, Switzerland., Gräni C; Department of Cardiology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland., Stämpfli SF; Department of Cardiology, Heart Centre Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.; Center for Molecular Cardiology, University of Zurich, Switzerland., Cuddy SAM; Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; CV Imaging Program, Cardiovascular Division, Department of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Clerc OF; Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; CV Imaging Program, Cardiovascular Division, Department of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Pabón AJR; Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; CV Imaging Program, Cardiovascular Division, Department of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Vijayakumar S; Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; CV Imaging Program, Cardiovascular Division, Department of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Ben Zadok OI; Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; CV Imaging Program, Cardiovascular Division, Department of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Falk RH; Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; CV Imaging Program, Cardiovascular Division, Department of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Dorbala S; Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; CV Imaging Program, Cardiovascular Division, Department of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Benz DC; Cardiac Imaging, Department of Cardiology and Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, Zurich CH-8091, Switzerland.; Advanced Clinician Scientist Program, University Medicine Zurich (UMZH), University of Zurich, Rämistrasse 71, Zurich CH-8091, Switzerland.
Source: European heart journal. Cardiovascular Imaging [Eur Heart J Cardiovasc Imaging] 2026 Feb 27; Vol. 27 (3), pp. 452-466.
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101573788 Publication Model: Print Cited Medium: Internet ISSN: 2047-2412 (Electronic) Linking ISSN: 20472404 NLM ISO Abbreviation: Eur Heart J Cardiovasc Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2047-2412
DOI:10.1093/ehjci/jeaf347